The company, which also manages the XTEND and Cellucor brands, is positioning itself for a debut after a period of expansion. In 2022, Keurig Dr Pepper secured a 30% stake in the business through an $863 million cash investment, a deal that pegged the company’s equity valuation at $2.88 billion. Nutrabolt has signaled strong financial momentum, reporting in September that it was on track to eclipse $1 billion in annual revenue.

This push comes as the broader U.S. IPO landscape shows signs of revival following a lengthy period of stagnation. However, the path for consumer and supplement brands remains volatile. Competitors such as Celsius Holdings have faced year-to-date share price declines of 38%, while the performance of other industry peers has been inconsistent. By leveraging the backing of major investment banks, Nutrabolt intends to navigate these shifting market conditions to test investor appetite for its diverse portfolio of recovery mixes, protein powders, and energy products.